As a cytoplasmic HDAC, HDAC6 has been implicated in the regulation of many cancer-associated cellular events and signaling pathways, making it an attractive target for cancer chemotherapy (Aldana-Masangkay and Sakamoto, 2011; Dallavalle et al., 2012). Here, HDAC6 is linked to cancer.